http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111467510-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K101-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
filingDate 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111467510-B
titleOfInvention Specific targeting radionuclide marker and preparation method and application thereof
abstract The invention provides a specific targeting radionuclide marker and a preparation method and application thereof, belonging to the technical field of nano medicine and molecular imaging. The tumor cell nucleus targeted fluorescent nanoprobe (GTTN) based on graphene is used as a cell nucleus targeted molecule to mark the radionuclide, and the obtained marker can be directly used for Single Photon Emission Computed Tomography (SPECT) and positron emission computed tomography (PET) of a tumor region and can be used for radionuclide treatment; in addition, the marker can highly target a tumor region by utilizing a cell membrane permeability targeting mechanism of GTTN, can realize bimodal imaging through fluorescence imaging of GTTN and SPECT or PET imaging of radionuclide, achieves the effects of accurate diagnosis and treatment, simultaneously reduces the side effect of the radionuclide on normal tissues to the maximum extent, and has good clinical application prospect.
priorityDate 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID450233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407611241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415723855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415824855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121841

Total number of triples: 32.